These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 16777581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N, Kingsley GH, Manzo A, Scott DL, Pitzalis C.
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [Abstract] [Full Text] [Related]

  • 3. Biological therapies in the spondyloarthritides--the current state.
    Braun J, Sieper J.
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ankylosing spondylitis and current disease-controlling agents: do they work?
    Maksymowych WP, Breban M, Braun J.
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):619-30. PubMed ID: 12406430
    [Abstract] [Full Text] [Related]

  • 6. Tumour necrosis factor inhibitors in ankylosing spondylitis.
    Reed MR, Taylor AL.
    Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The treatment of ankylosing spondylitis.
    Scalapino KJ, Davis JC.
    Clin Exp Med; 2003 Feb; 2(4):159-65. PubMed ID: 12624705
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN, Kapoor S, Garg S, Ahmad I, Raja RR.
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N.
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [Abstract] [Full Text] [Related]

  • 19. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV, Arce-Salinas CA, Guzmán-Vázquez S, Cardiel-Ríos MH.
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [Abstract] [Full Text] [Related]

  • 20. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J.
    Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.